(Q35073279)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605547%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

review article

1 reference

title

Candidate gene case-control studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605547%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605547%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

Ann K Daly

series ordinal

1

1 reference

6 August 2017

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605547%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605547%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605547%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605547%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

127-139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605547%20AND%20SRC:MED&resulttype=core&format=json

Pharmacogenetics and the practice of medicine

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Searching for genetic determinants in the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

How many diseases does it take to map a gene with SNPs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

How many SNPs does a genome-wide haplotype map require?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Asymptotic bias and efficiency in case-control studies of candidate genes and gene-environment interactions: basic family designs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Role of gene expression microarray analysis in finding complex disease genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Single nucleotide polymorphism libraries: why and how are we building them?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

What's wrong with Bonferroni adjustments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Proper controls for SNP studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Use of parents, sibs, and unrelated controls for detection of associations between genetic markers and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

The power of genomic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Use of unlinked genetic markers to detect population stratification in association studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Association mapping in structured populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Genetic analysis of autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

From genome to aetiology in a multifactorial disease, type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Candidate gene approach for pharmacogenetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

A comprehensive review of genetic association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Molecular genetics of cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P45 0IA1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Genetic Linkage of Lung Cancer-Associated MspI Polymorphisms with Amino Acid Replacement in the Heme Binding Region of the Human Cytochrome P450IA1 Gene1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Lung cancer and the debrisoquine metabolic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

CYP2D6 genotype and lung cancer risk according to histologic type and tobacco exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Nicotine metabolism defect reduces smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Genetic variation of CYP2A6, smoking, and risk of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Relationship between acetylator status, smoking, and diet and colorectal cancer risk in the north-east of England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Human DNA repair systems: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Microsomal epoxide hydrolase polymorphisms and lung cancer risk: a quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Lung cancer risk in relation to genetic polymorphisms of microsomal epoxide hydrolase among African-Americans and Caucasians in Los Angeles County.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Genetic polymorphism of XRCC1 and lung cancer risk among African-Americans and Caucasians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

XRCC1 genetic polymorphism and breast cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Variants in DNA double-strand break repair genes and breast cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Genetic polymorphisms in DNA repair genes and risk of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

Polymorphisms of human aryl hydrocarbon receptor (AhR) gene in a French population: relationship with CYP1A1 inducibility and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.127.22629

10.1517/PHGS.4.2.127.22629

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605547%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference